Please assess the completion status of the following clinical trial:

Trial Title: Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients receiving maintenance hemodialysis or continuous ambulatory peritoneal dialysis, and dialysis vintage more than 3 months~* Patients aged between 18 and 80 years older~* VitC \< 4ug/ml and hsCRP \> 3mg/L~* for HD patients, Kt/V \> 1.2 per session, at least 3 sessions per week, 4 hours per session~* for PD patients, Kt/V \> 1.7 per week~* age and gender matched health control~Exclusion Criteria:~* Active autoimmune disease, malignancy, hepatitis~* Positive HIV serology~* Any kind of acute infection within one month, chronic infection~* Currently using steroids or immune-suppressants~* Pregnancy or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- arm1, vitamin C treated first (Type: OTHER): Arm 1(50cases): intervention with oral vitamin C 200mg per day in the first 3 months, then stop oral VitC for the next 3 months.
- Arm 2 control first (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).